Seres Therapeutics, Inc. Total Long-Term Debt
Seres Therapeutics, Inc. (MCRB) had Total Long-Term Debt of $110.00 million as of 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2024-08-15
- 2024-06-30: Long-term Debt $110.00M.
- 2024-03-31: Long-term Debt $110.00M.
- 2023-12-31: Long-term Debt $110.00M.
- 2023-09-30: Long-term Debt $110.00M.
| Period end | Long-term Debt |
|---|---|
| 2024-06-30 | $110.00M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $110.00M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $110.00M 8-K · filed 2024-08-15 |
| 2023-09-30 | $110.00M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $110.00M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $50.00M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $50.00M 10-K · filed 2023-03-07 |
| 2022-09-30 | $50.00M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $50.00M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $50.00M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $24.05M 10-K · filed 2022-03-01 |
| 2021-09-30 | $25.00M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $25.00M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $25.00M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $25.00M 10-K · filed 2021-03-02 |
| 2020-09-30 | $25.00M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $25.00M 10-Q · filed 2020-07-28 |
| 2020-03-31 | $25.00M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $25.00M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |